| Size & multiples | |||
| Market Cap | $1.18B | Enterprise Value | — |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | 4.07× | P/FCF | — |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | — | EV/FCF | — |
| FCF Yield | −4.65% | Buyback Yield | 0.55% |
| Owner Earnings (TTM) | -$17.7M | Owner Earnings Yield | −1.50% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 1.27 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 10.33% |
| After-tax Cost of Debt | — | WACC | — |
| ROIC | — | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
FCF sits 210% below owner earnings — spending above maintenance (growth capex) or absorbing working capital, so FCF understates the steady-state cash the business throws off.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM -$1.62 · revenue TTM $290.4M · FCF TTM -$55.0M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| FCF Yield | -3.4% | -7.9% | -35.6%–1.4% | 60 ↑strong |
| Net Margin | -33.6% | -21.2% | -325.3%–7.2% | 45 ↓weak |
| Operating Margin | -38.3% | -34.5% | -552.0%–8.0% | 49 ↓weak |
| ROE | -21.7% | -36.8% | -92.5%–4.5% | 59 ↑strong |
